The Alliance for Heart Failure is a coalition of charities, patient groups, professional bodies, public sector organisations and corporate members working together to raise the profile of heart failure within the Government, the National Health Service, and media. It was formed in October 2015.
The Alliance for Heart Failure's mission is to achieve better outcomes for people with heart failure by ensuring timely diagnosis and access to the right care and support.
Video Alliance for Heart Failure
Membership
Current members of the Alliance for Heart Failure are:
- Bayer Pharmaceuticals
- British Association for Nursing in Cardiovascular Care
- British Society for Echocardiography
- British Society for Heart Failure
- Cardiomyopathy UK
- Cardiovascular Care Partnership UK
- Kent Surrey Sussex Academic Health Science Network
- Medtronic UK
- National Heart & Lung Institute
- Novartis Pharmaceuticals UK Ltd
- Pumping Marvellous Foundation
- Roche Diagnostics Ltd
- South East Clinical Networks
Maps Alliance for Heart Failure
Organisation
The inaugural Co-Chairs are Angela Graves (Pumping Marvellous Foundation) and Professor Andrew Clark (British Society for Heart Failure). They have a 12-month tenure. Day-to-day decisions are made by a steering committee.
The Alliance for Heart Failure is supported and funded by Bayer, Medtronic Limited, Novartis Pharmaceuticals UK Ltd, and Roche Diagnostics Ltd. Funders are not responsible for any of the materials produced by the Alliance for Heart Failure, which are created independently by the Alliance's Secretariat.
The All Party Parliamentary Group on Heart Disease Inquiry into heart failure
In 2016, the The All Party Parliamentary Group]] (APPG) on Heart Disease, chaired by Stuart Andrew MP, held an inquiry into living with heart failure. Written and oral evidence was provided by patients, healthcare professionals, and commissioners. The Inquiry's report, Focus on Heart Failure, was published in September 2016 and made ten recommendations for improving heart failure services.
Nine members of the Alliance for Heart Failure were co-opted onto an Advisory Panel for the Inquiry. The panel had ten members in total.
National Heart Failure Audit
The National Heart Failure Audit (April 2015-March 2016), published on August 10, 2017, reported that mortality among patients admitted to hospital had fallen to 8.9% compared to 9.6% reported in the previous audit. It also reported that the number of patients seen by specialist heart failure nurses remains high at 80 per cent, and that 90 per cent of patients are recorded as having an up to date echocardiogram. The report also recorded an increase in prescriptions for disease modifying medications.
The Alliance for Heart Failure welcomed the findings but called for more to be done to address the vast regional variation in patient outcomes.
References
Source of the article : Wikipedia
0 Comments